Literature DB >> 3863121

Adenine ribo- and deoxyribonucleotide metabolism in human erythrocytes, B- and T-lymphocyte cell lines, and monocyte-macrophages.

W N Valentine, D E Paglia, S Clarke, B H Morimoto, M Nakatani, R Brockway.   

Abstract

Ordinarily packaged in DNA, adenine deoxyribonucleotides are preferentially concentrated in erythrocyte and lymphocyte cytosol in adenosine deaminase (adenosine aminohydrolase, EC 3.5.4.4) deficiency. A spectrum of cytosol enzyme activities are defined in terms of reaction velocities, K0.5s, and nucleotide partition after incubation with ribo- and deoxyribonucleotides. AMP and dAMP were dephosphorylated, but only AMP was deaminated in vitro. Although nucleotidase activity is much stronger in lymphocytes, AMP deaminase was the dominant degradative reaction in all erythrocyte and lymphocyte lysates under the conditions specified. For most cytosolic enzymes, ribonucleotides were preferred cofactors, implying that dADP and dATP often may be bystanders at metabolic events. The adenylate kinase-mediated partition of approximately equimolar ribo- and deoxyribonucleotide substrates yielded a very large preponderance of AMP in the monophosphate compartment, the monophosphates alone being directly vulnerable to degradative loss. The adenylate kinase(s) of lymphocytes differed strikingly from those of erythrocytes in reaction velocities with nucleotide cofactors, K0.5s, and in susceptibility to substrate inhibition.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3863121      PMCID: PMC391274          DOI: 10.1073/pnas.82.19.6682

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  38 in total

1.  Effects of mutational loss of adenosine kinase and deoxycytidine kinase on deoxyATP accumulation and deoxyadenosine toxicity in cultured CEM human T-lymphoblastoid cells.

Authors:  M S Hershfield; J E Fetter; W C Small; A S Bagnara; S R Williams; B Ullman; D W Martin; D B Wasson; D A Carson
Journal:  J Biol Chem       Date:  1982-06-10       Impact factor: 5.157

2.  Identification of thymidine nucleotidase and deoxyribonucleotidase activities among normal isozymes of 5'-nucleotidase in human erythrocytes.

Authors:  D E Paglia; W N Valentine; R A Brockway
Journal:  Proc Natl Acad Sci U S A       Date:  1984-01       Impact factor: 11.205

3.  DNA strand breaks induced in human T-lymphocytes by the combination of deoxyadenosine and deoxycoformycin.

Authors:  L Brox; A Ng; E Pollock; A Belch
Journal:  Cancer Res       Date:  1984-03       Impact factor: 12.701

4.  Partial purification of some red cell enzymes utilizing hemoglobin precipitation by zinc salts.

Authors:  W N Valentine; D E Paglia
Journal:  J Lab Clin Med       Date:  1983-04

5.  Regulation of purine metabolism by plasma membrane and cytoplasmic 5'-nucleotidases.

Authors:  N L Edwards; D Recker; J Manfredi; R Rembecki; I H Fox
Journal:  Am J Physiol       Date:  1982-11

6.  Characterization of an adenosine 5'-triphosphate- and deoxyadenosine 5'-triphosphate-activated nucleotidase from human malignant lymphocytes.

Authors:  D A Carson; D B Wasson
Journal:  Cancer Res       Date:  1982-11       Impact factor: 12.701

7.  Purine deoxynucleoside toxicity in nondividing human lymphoid cells.

Authors:  R F Kefford; R M Fox
Journal:  Cancer Res       Date:  1982-01       Impact factor: 12.701

8.  Purine metabolizing enzymes as predictors of lymphoblast sensitivity to deoxyadenosine.

Authors:  B S Mitchell; N L Edwards
Journal:  J Lab Clin Med       Date:  1984-09

9.  Factors regulating the activities of the low density lipoprotein receptor and the scavenger receptor on human monocyte-macrophages.

Authors:  A M Fogelman; M E Haberland; J Seager; M Hokom; P A Edwards
Journal:  J Lipid Res       Date:  1981-09       Impact factor: 5.922

10.  Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.

Authors:  D A Carson; D B Wasson; E Lakow; N Kamatani
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.